NYSE · ROK

Rockwell Automation, Inc.

$462.16 +$1.51 (+0.33%) 1D After hours
Charting by TradingView

Key Metrics

$51.26B
Market cap
47.11×
P/E · TTM
$8.80B
Revenue · TTM
$1.09B
Net income
EPS · TTM $9.65
Dividend yield 1.2%
Free cash flow $1.34B
Beta · 1Y 1.51
EBITDA · TTM $1.51B
Gross margin 52.5%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    Money has been moving out of its sector (Technology).

    Technology has run -4.1 points vs SPY over four weeks, ranking 8→2→11→7 of 11 sectors — this stock trades inside that current.

    RECEIPT: ROTATION MAP, LIVE ↗
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 5
    The stock moved +8.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 5

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$51.26B
Enterprise value$53.22B
Shares outstanding111.3M
52-wk range$305.44 – $497.36
Avg volume · 20D812.0K
Net cash −$1.96B
Book value / share$31.25
IndustryMeasuring & Controlling Devices, Nec
ExchangeNYSE
About Rockwell Automation, Inc.
IPO dateAug 29, 1956
Employees26000

With roots tracing back to the early 1900s, Rockwell Automation is the successor to Rockwell International, which spun off its avionics segment in 2001. It is a pure-play industrial automation company that operates through three segments.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E47.11
P/S5.82
P/FCF38.28
EV/EBITDA35.29
EV/Sales6.04
Graham №$82.39

Profitability

Gross 52.5%
Operating 13.5%
Net 12.4%
FCF 15.2%
ROE / ROIC 31.0% · 17.2%

Financial Health

Current ratio1.09
Quick ratio0.76
Debt / equity0.73
Debt / EBITDA 1.71
Net cash −$1.96B
Working capital$340.00M

Cash Flow · TTM

Operating CF $1.54B
Capex −$196.00M
Free cash flow $1.34B
Buybacks $792.00M
Dividends paid $603.00M
Shareholder yield 2.7%

Piotroski F-Score

6 / 9
Middling fundamentals · 6 of 9 signals passing

Altman Z-Score

—
Insufficient balance-sheet inputs

Graham Number vs Price

$82.39 vs $462.16
Trades 5.6× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings